Mohammad Hirmand - Net Worth and Insider Trading
Mohammad Hirmand Net Worth
The estimated net worth of Mohammad Hirmand is at least $6 Million dollars as of 2024-11-05. Mohammad Hirmand is the Interim Chief Medical Officer of Medivation Inc and owns about 39,342 shares of Medivation Inc (MDVN) stock worth over $3 Million. Mohammad Hirmand is also the EVP & Chief Medical Officer of Turning Point Therapeutics Inc and owns about 40,821 shares of Turning Point Therapeutics Inc (TPTX) stock worth over $3 Million. Details can be seen in Mohammad Hirmand's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mohammad Hirmand has not made any transactions after 2022-02-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mohammad Hirmand
Mohammad Hirmand Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mohammad Hirmand owns 3 companies in total, including Turning Point Therapeutics Inc (TPTX) , Medivation Inc (MDVN) , and Aadi Bioscience Inc (AADI) .
Click here to see the complete history of Mohammad Hirmand’s form 4 insider trades.
Insider Ownership Summary of Mohammad Hirmand
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TPTX | Turning Point Therapeutics Inc | 2022-02-09 | EVP and Chief Medical Officer |
| MDVN | Medivation Inc | 2016-09-28 | Interim Chief Medical Officer |
| AADI | Aadi Bioscience Inc | 2023-03-27 | director |
Mohammad Hirmand Latest Holdings Summary
Mohammad Hirmand currently owns a total of 2 stocks. Among these stocks, Mohammad Hirmand owns 39,342 shares of Medivation Inc (MDVN) as of March 4, 2016, with a value of $3 Million and a weighting of 50.8%. Mohammad Hirmand also owns 40,821 shares of Turning Point Therapeutics Inc (TPTX) as of February 9, 2022, with a value of $3 Million and a weighting of 49.2%.
Latest Holdings of Mohammad Hirmand
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MDVN | Medivation Inc | 2016-03-04 | 39,342 | 81.44 | 3,204,012 |
| TPTX | Turning Point Therapeutics Inc | 2022-02-09 | 40,821 | 76.01 | 3,102,804 |
Holding Weightings of Mohammad Hirmand
Mohammad Hirmand Form 4 Trading Tracker
According to the SEC Form 4 filings, Mohammad Hirmand has made a total of 0 transactions in Medivation Inc (MDVN) over the past 5 years. The most-recent trade in Medivation Inc is the sale of 1,525 shares on March 4, 2016, which brought Mohammad Hirmand around $62,678.
According to the SEC Form 4 filings, Mohammad Hirmand has made a total of 2 transactions in Turning Point Therapeutics Inc (TPTX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Turning Point Therapeutics Inc is the sale of 669 shares on February 9, 2022, which brought Mohammad Hirmand around $24,285.
Insider Trading History of Mohammad Hirmand
- 1
Mohammad Hirmand Trading Performance
Mohammad Hirmand Ownership Network
Ownership Network List of Mohammad Hirmand
Ownership Network Relation of Mohammad Hirmand
Mohammad Hirmand Owned Company Details
What does Turning Point Therapeutics Inc do?
Who are the key executives at Turning Point Therapeutics Inc?
Mohammad Hirmand is the EVP and Chief Medical Officer of Turning Point Therapeutics Inc. Other key executives at Turning Point Therapeutics Inc include EVP & Chief Financial Officer Paolo Tombesi , SVP & Chief Commercial Officer Steve M Sabus , and SVP & General Counsel Brian Sun .
Turning Point Therapeutics Inc (TPTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Turning Point Therapeutics Inc (TPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turning Point Therapeutics Inc (TPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Turning Point Therapeutics Inc (TPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Turning Point Therapeutics Inc Insider Transactions
Mohammad Hirmand Mailing Address
Above is the net worth, insider trading, and ownership report for Mohammad Hirmand. You might contact Mohammad Hirmand via mailing address: C/o Medivation, Inc., 525 Market St., 36th Floor, San Francisco Ca 94105.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
